KennethBruceAinMD(He/Him)
Endocrinology • Lexington, KYThyroid
Founder and former Director, Thyroid Oncology Program
Dr. Ain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2336 Abbeywood Rd
Lexington, KY 40515Phone+1 859-806-3035Fax+1 859-806-3035
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1987
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1981 - 1984
The Warren Alpert Medical School of Brown UniversityClass of 1981
Certifications & Licensure
KY State Medical License 1990 - 2025
MD State Medical License 1987 - 1992
PA State Medical License 1982 - 1992
IL State Medical License 1984 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- America's Top Doctors for Cancer Castle Connolly, 2007-2013
Clinical Trials
- Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer Start of enrollment: 1999 Jul 01
- Thalidomide in Treating Patients With Thyroid Cancer Start of enrollment: 2001 Jun 01
- REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas Start of enrollment: 2006 Feb 01
Publications & Presentations
PubMed
- 245 citations2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer: American Thyroid Association Anaplastic Thyroid Cancer Guidelin...Keith C. Bible, Electron Kebebew, James Brierley, Juan P. Brito, Maria E. Cabanillas
Thyroid. 2021-03-01 - 8 citationsAssociation of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?Elif Hindié, Kenneth B. Ain, Slimane Zerdoud, Anca M. Avram
The Journal of Clinical Endocrinology and Metabolism. 2020-04-01 - 14 citationsReassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at DiagnosisDonald S. A. McLeod, Jacqueline Jonklaas, James D. Brierley, Kenneth B. Ain, David S. Cooper
Thyroid. 2015-09-24
Press Mentions
Hypothyroidism May Lead to Impaired DrivingJune 23rd, 2014
Grant Support
- Transcriptional Repression Of Sodium-Iodide Symporter In Thyroid CarcinomaNational Cancer Institute2008–2011
- Phase II Trial Of ThalidimideNational Center For Research Resources2004
- Demethylation Therapy Of Thyroid CarcinomaNational Cancer Institute2000–2004
- Restoration Of Radioiodine Uptake In Thyroid CarcinomaNational Center For Research Resources2000–2002
- Restoration Of Radioiodine Uptake In Thyroid Carcinoma--Clinical TrialNational Center For Research Resources1998–1999
- Thyroid Carcinoma Inhibition By SomatostatinNational Cancer Institute1994–1998
Professional Memberships
- Member
- Member
- Endocrine Ethics AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
